Hemophilia Treatment Center - Case Studies
Gene therapy for hemophilia B has just received approval from both the EMA and FDA. A 20-year-old patient with severe hemophilia B comes to your HTC for a regular visit and expresses interest in getting treatment with gene therapy. How would you respond to the following questions regarding the decision making process, the administration of treatment, and post-treatment monitoring?
Watch Wolfgang Miesbach, MD and his Colleagues Discuss Treatment Questions
Download Treatment Question Responses from Steve Pipe, MD and his Colleagues
